Developing treatments for serious infections caused by dangerous pathogens
Antiviral & Antimicrobial Countermeasures Discovery and Development Core
This study is looking for new medicines to help treat serious infections caused by tough germs, using special technology to see how these drugs work, and it's all done in a safe lab to help find better treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tennessee Health Sci Ctr NIH-funded |
| Lab location | 1 site (Memphis, United States) |
| Project ID | NIH-10910184 on NIH RePORTER |
What this research studies
This research focuses on discovering and developing new antiviral and antimicrobial treatments for serious infections caused by high-risk pathogens. It utilizes advanced technologies for screening potential drugs, imaging infected tissues, and analyzing drug effects on pathogens. The research is conducted in a specialized laboratory designed to safely handle these dangerous pathogens, ensuring that findings can lead to effective therapies for patients. By studying how drugs interact with infections, the project aims to improve treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of infections from biosafety level 2 or 3 pathogens, such as those with compromised immune systems or specific health conditions.
Not a fit: Patients with infections caused by low-risk pathogens or those not requiring specialized antiviral or antimicrobial treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new and effective treatments for infections caused by dangerous pathogens, improving patient health outcomes.
How similar studies have performed: Previous research has shown success in developing treatments for similar high-risk pathogens using advanced drug discovery methods, indicating a promising approach.
Where this research is happening
Memphis, United States
- University of Tennessee Health Sci Ctr — Memphis, United States (Active)
Researchers
- Principal investigator: Jonsson, Colleen B — University of Tennessee Health Sci Ctr
- Study coordinator: Jonsson, Colleen B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.